Andrew S. Davis - Oct 3, 2022 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Oct 3, 2022
Transactions value $
-$292,405
Form type
4
Date filed
10/5/2022, 08:36 PM
Previous filing
Sep 2, 2022
Next filing
Nov 1, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $9.86K +6.75K +6.88% $1.46* 105K Oct 3, 2022 Direct F1
transaction SILK Common Stock Sale -$302K -6.75K -6.43% $44.76 98.2K Oct 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -6.75K -42.23% $0.00 9.24K Oct 3, 2022 Common Stock 6.75K $1.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2 All of the shares subject to this option are fully vested and exercisable as of the date hereof.